Search

Your search keyword '"Ahmadi, Arezoo"' showing total 161 results
Start Over Author "Ahmadi, Arezoo"
161 results on '"Ahmadi, Arezoo"'

3. Successful Treatment of Pulmonary Embolism Causing Cardiac Arrests with Reteplase during Neurosurgery: A Case Report.

Author

Yousefi-Mazhin, Ehsan, Mojtahedzadeh, Mojtaba, Karballaei-Mirzahosseini, Hossein, Hassanpour, Rezvan, Sharifnia, Hamidreza, Najmeddin, Farhad, Ameli, Amirhossein, Khadem-Abbasi, Mohammad Javad, Fotouhi, Mansoureh, Etezadi, Farhad, Khajavi, Mohammad Reza, Moharari, Reza Shariat, Pourfakhr, Pejman, Ahmadi, Arezoo, Neishaboury, Mohammad Reza, and Najafi, Atabak

Published
2024

4. Protective Effects of Intravenous Magnesium Sulfate in Stroke Patients Receiving Amiodarone: A Randomized Controlled Trial

Author

Panahi, Yunes, Mojtahedzadeh, Mojtaba, Najafi, Atabak, Gheini, Mohammadreza, Abdollahi, Mohammad, Sharifzadeh, Mohammad, Ahmadi, Arezoo, Ganjali, Shiva, Rajaee, Seyyed Mahdi, Barreto, George E., Sahebkar, Amirhossein, Crusio, Wim E., Series Editor, Dong, Haidong, Series Editor, Radeke, Heinfried H., Series Editor, Rezaei, Nima, Series Editor, Xiao, Junjie, Series Editor, Steinlein, Ortrud, Series Editor, Barreto, George E., editor, and Sahebkar, Amirhossein, editor

Published
2021
Full Text
View/download PDF

8. Protective Effects of Intravenous Magnesium Sulfate in Stroke Patients Receiving Amiodarone: A Randomized Controlled Trial

Author

Panahi, Yunes, primary, Mojtahedzadeh, Mojtaba, additional, Najafi, Atabak, additional, Gheini, Mohammadreza, additional, Abdollahi, Mohammad, additional, Sharifzadeh, Mohammad, additional, Ahmadi, Arezoo, additional, Ganjali, Shiva, additional, Rajaee, Seyyed Mahdi, additional, Barreto, George E., additional, and Sahebkar, Amirhossein, additional

Published
2021
Full Text
View/download PDF

9. Successful management of severe generalized tetanus in a 23‐year man with phenobarbital adjuvant: A case report.

Author

Ahmadi, Arezoo, Karimpour‐Razkenari, Elahe, Ansari, Ramin, Marashi, Mahforouzalsadat, Sharifnia, Hamidreza, Najafi, Atabak, and Mojtahedzadeh, Mojtaba

Subjects
*TETANUS, *PHENOBARBITAL, *INTENSIVE care units, *TRISMUS, *MIDDLE-income countries
Abstract

Key Clinical Message: Generalized tetanus is still a global concern with a mortality rate of up to 50%, especially in low and middle‐income countries. We reported a 23‐year‐old man from Afghanistan admitted to emergency department, with the chief complaint of generalized severe spasms and lockjaw. The patient had skin lesions and had never been vaccinated against tetanus. He intubated and admitted to the intensive care unit (ICU) with diagnose of severe generalized tetanus. After receiving tetanus immunoglobulin and intravenous metronidazole, a combination therapy of midazolam, propofol, atracurium, and morphine was administered. Due to the refractory muscular spasms intravenous phenobarbital started and little by little recovery was achieved. The patient receiving the first two doses of the Td vaccine, and discharged on Day 42 of hospitalization with no symptom recurrence. This case management showed adding phenobarbital to severe tetanus treatment regimen could significantly reduce refractory spasm caused by tetanus, also decrease other medication requirement. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

10. Correlation of biofilm formation, virulence factors, and phylogenetic groups among Escherichia coli strains causing urinary tract infection: A global systematic review and meta-analysis.

Author

Mirzahosseini, Hossein Karballaei, Najmeddin, Farhad, Najafi, Atabak, Ahmadi, Arezoo, Sharifnia, Hamidreza, Khaledi, Azad, and Mojtahedzadeh, Mojtaba

Subjects
ESCHERICHIA coli, ONLINE information services, PHYLOGENY, META-analysis, CONFIDENCE intervals, URINARY tract infections, SYSTEMATIC reviews, BIOFILMS, DESCRIPTIVE statistics, MICROBIAL virulence, MEDLINE
Abstract

Background: Different virulence factors are involved in the pathogenesis of urinary tract infection (UTI) caused by Uropathogenic Escherichia coli (UPEC); hence, this study aimed to study the prevalence of biofilm formation, virulence factors, and phylogenetic groups and their correlation with biofilm formation among UPEC isolates through a systematic review and meta-analysis. Materials and Methods: A literature search was conducted from 1, 2000, to the end of 2021 in different databases for studies that reported biofilm together with virulence genes or phylogenetic groups in UPEC isolates from patients with UTI according to PRISMA protocol. Data were analyzed by Comprehensive meta-analysis software. Results: The pooled prevalence of biofilm formers was 74.7%. The combined prevalence of phylogenetic Groups A, B1, B2, and D (s) were reported at 19.6%, 11%, 50.7%, and 20.5%, respectively. The most common virulence genes reported worldwide were fimA, ecpA, and fimH, with a combined prevalence of 90.3%, 86.6%, and 64.9%, respectively. The pooled prevalence of biofilm formation in UPEC isolates with phylogenetic Groups A, B1, B2, D, C, and F were 12.4%, 8.7%, 33.7%, 12.4%, 2.6%, and 2.65%, respectively. Several studies showed a correlation between biofilm production and virulence genes, or phylogenetic groups. Conclusion: Regarding data obtained, the high level of combined biofilm formation (74.7%) and the presence of a positive correlation between biofilm production and virulence genes, or phylogenetic groups as reported by the most studies included in the present review, indicates an important role of biofilm in the persistence of UPEC in the UTI. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

13. Alveolar air leak and paraseptal emphysema in severe COVID-19 disease

Author

Najafi, Atabak, Fallahian, Farahnaz, Ahmadi, Arezoo, Bakhtavar, Khadijeh, and Daoud, Ehab

Subjects
body regions, acute respiratory failure, COVID-19, respiratory system, Alveolar air leak syndrome, paraseptal emphysema, humanities, respiratory tract diseases
Abstract

Background Corona virus 2019 (COVID-19) pandemic spread in the world as a great medical crisis. Its pathophysiology, manifestations, complications, and management are not completely defined, yet. In this study frequency of alveolar air leak in critically ill COVID-19 subjects is explored. Methods A total of 820 critically ill COVID-19 subjects who admitted with respiratory insufficiency to ICUs of Sina University Hospital from March 2020 to June 2021 were included. All their chest x ray (CXR) and Computed tomography (CT) of chest were reviewed. All alveolar air leak episodes (pneumothorax, pneumomediastinum, pneumopericardium, subcutaneous emphysema) suspected films reviewed by attending intensivist and radiologist. Results Of the 820 ill COVID-19 subjects in ICUs, 492(60%) were male, and 328 (40%) were female. The Mean age of 820 subjects was 60.84 + 16.82. 584 (71.22%) of subjects were non-intubated, and 236 (28.78%) were intubated. Alveolar air leak occurred in 98 (11.95%) of subjects. Alveolar air leak episodes include pneumothorax in 26 (3.17%), subcutaneous emphysema in 72 (8.78%), pneumomediastinum in 9 (1.10%), and pneumopericardium in 1 (0.12%) of subjects. The mean age in non-intubated subjects was 59.65 + 16.84, and for intubated subjects was 63 + 16.42. There was a significant difference in age between the groups who get intubated, versus not intubated P 0.001. Of the 584 non-intubated subjects, 31 (5.31%) had subcutaneous emphysema, of the 236 intubated subjects, 41 (17.37%) had subcutaneous emphysema. Difference between groups was statistically significant, P

Published
2021

15. Effects of Remdesivir on In-Hospital and Late Outcomes of Patients With Confirmed or Clinically Suspected COVID-19: A Propensity Score-Matched Study

Author

Hadadi, Azar, primary, Ajam, Ali, additional, Montazeri, Mahnaz, additional, Kafan, Samira, additional, Veisizadeh, Abdolazim, additional, Ghoghaei, Morteza, additional, Kazemian, Sina, additional, Ahmadi, Arezoo, additional, Majidi, Fazeleh, additional, Moghadasi, Maryam, additional, Kashani, Mehdi, additional, Ghasemi, Faezeh, additional, and Pazoki, Marzieh, additional

Published
2022
Full Text
View/download PDF

25. Effects of curcuminoids on inflammatory and oxidative stress biomarkers and clinical outcomes in critically ill patients: A randomized double‐blind placebo‐controlled trial

Author

Zahedi, Hoda, primary, Hosseinzadeh‐Attar, Mohammad Javad, additional, Shadnoush, Mahdi, additional, Sahebkar, Amirhossein, additional, Barkhidarian, Bahareh, additional, Sadeghi, Omid, additional, Najafi, Atabak, additional, Hosseini, Saeed, additional, Qorbani, Mostafa, additional, Ahmadi, Arezoo, additional, Ardehali, Seyed Hossein, additional, and Norouzy, Abdolreza, additional

Published
2021
Full Text
View/download PDF

27. Evaluating the Neuroprotective Effect of Melatonin on Patients with Hemorrhagic Stroke Using Serum S100B Protein as a Prognostic Marker

Author

Sharifnia, Hamidreza, primary, Mojtahedzadeh, Mojtaba, additional, Dianatkhah, Mehrnoush, additional, Najafi, Atabak, additional, Ahmadi, Arezoo, additional, Najmeddin, Farhad, additional, Dianatkhah, Minoo, additional, Alizadeh, Nafiseh, additional, Jafari, Atefeh, additional, Izadpanah, Mandana, additional, Parvin, Shahram, additional, and Daei, Maryam, additional

Published
2021
Full Text
View/download PDF

28. Vasopressin in septic shock; assessment of sepsis biomarkers: A randomized, controlled trial

Author

Barzegar, Elchin, Nouri, Masoumeh, Mousavi, Sarah, Ahmadi, Arezoo, and Mojtahedzadeh, Mojtaba

Subjects
Vasopressins -- Dosage and administration, Septic shock -- Drug therapy -- Research, Sepsis -- Research, Biological markers -- Research, Health
Abstract

Byline: Elchin. Barzegar, Masoumeh. Nouri, Sarah. Mousavi, Arezoo. Ahmadi, Mojtaba. Mojtahedzadeh Background and Aims: Vasopressin (VP) in sepsis apart from vasoconstrictive effect may have some immunomodulatory effects. The aim of [...]

Published
2017

29. The effect of high-dose parenteral sodium selenite in critically ill patients following sepsis: A clinical and mechanistic study

Author

Chelkeba, Legese, Ahmadi, Arezoo, Abdollahi, Mohammad, Najafi, Atabak, Ghadimi, Mohammad, Mosaed, Reza, and Mojtahedzadeh, Mojtaba

Subjects
Septic shock -- Drug therapy -- Research, Selenium compounds -- Dosage and administration, Treatment outcome -- Analysis, Health
Abstract

Byline: Legese. Chelkeba, Arezoo. Ahmadi, Mohammad. Abdollahi, Atabak. Najafi, Mohammad. Ghadimi, Reza. Mosaed, Mojtaba. Mojtahedzadeh Introduction: Severe sepsis and septic shock is characterized by inflammation and oxidative stress. Selenium levels [...]

Published
2017

30. Prevalence of candidemia and associated candida subtypes following severe sepsis in non-neutropenic critically ill patients

Author

Kashiha, Arefeh, Setayesh, Neda, Panahi, Yunes, Ahmadi, Arezoo, Soltany-Rezaee-Rad, Mohammad, Najafi, Atabak, Rouini, Mohammad-Reza, Namipashaki, Atefeh, Sahebkar, Amirhossein, and Mojtahedzadeh, Mojtaba

Subjects
Male, Critical Illness, candidemia, Iran, Middle Aged, Real-Time Polymerase Chain Reaction, severe sepsis, Intensive Care Units, Cross-Sectional Studies, Sepsis, ICU, Prevalence, Humans, Original Article, Female, Real-Time PCR, DNA, Fungal, Candida
Abstract

Background: Invasive candidiasis management through the rapid initiation of appropriate antifungal therapy has been shown to be associated with the better prognosis, improved clinical outcome and reduced mortality in critically ill patients. Therefore, selection of an appropriate antifungal therapy should be based on the distribution of candida species and the pattern of antifungal resistance. This study aimed to assess the prevalence of candidemia and associated subtypes following severe sepsis in non-neutropenic critically ill patients. Methods: This study was a cross-sectional study that was conducted on severe sepsis patients stayed at least seven days in intensive care unit. Patients less than 18 years old, pregnant and breastfeeding patients, immunocompromised patients, neutropenic patients, patients with concurrent use of antifungal medicines and cytotoxic agents were excluded.To asses the candidemia, one mililiter of patients’ blood sample was collected. Sample analysis was performed by Real-Time PCR and high resolution melting curve analysis method. Results: Thirty-one critically ill patients were recruited in this study over 12-month period. Candidemia with a detection limit of 100 pg per 0.2 ml blood sample was not recognized in any of the included patients. Conclusion: The present result indicates low incidence of candidemia in the targeted intensive care units, but other factors such as small sample size, exclusion of patients with compromised immune system and the low fungal load at the time of sampling may also account for our observation. (www.actabiomedica.it)

Published
2018

31. Methadone Pharmacokinetics in Geriatric Critically Ill Patients Following Intramuscular and Intravenous Administration: A Pilot Stud

Author

Beik Rassouli, Safoura, primary, Rouini, Mohammad Reza, additional, Najmeddin, Farhad, additional, Gheimati, Azin, additional, A Golabchifar, Ali, additional, Tabib, Kimia, additional, Ahmadi, Arezoo, additional, Sadeghi, Kourosh, additional, Honarmand, Hooshyar, additional, Hadi, Ali Mohammed, additional, and Mojtahedzadeh, Mojtaba, additional

Published
2020
Full Text
View/download PDF

32. Effects of supplementation with curcuminoids on serum adipokines in critically ill patients: a randomized double‐blind placebo‐controlled trial

Author

Shadnoush, Mahdi, primary, Zahedi, Hoda, additional, Norouzy, Abdolreza, additional, Sahebkar, Amirhossein, additional, Sadeghi, Omid, additional, Najafi, Atabak, additional, Hosseini, Saeed, additional, Qorbani, Mostafa, additional, Ahmadi, Arezoo, additional, Ardehali, Seyed Hossein, additional, and Hosseinzadeh‐Attar, Mohammad Javad, additional

Published
2020
Full Text
View/download PDF

33. Early goal-directed therapy reduces mortality in adult patients with severe sepsis and septic shock: Systematic review and meta-analysis

Author

Chelkeba, Legese, Ahmadi, Arezoo, Abdollahi, Mohammad, Najafi, Atabak, and Mojtahedzadeh, Mojtaba

Subjects
Mortality -- Analysis -- India, Meta-analysis -- Usage, Septic shock -- Patient outcomes -- Analysis, Sepsis -- Diagnosis -- Care and treatment, Social class -- Analysis, Health
Abstract

Byline: Legese. Chelkeba, Arezoo. Ahmadi, Mohammad. Abdollahi, Atabak. Najafi, Mojtaba. Mojtahedzadeh Introduction: Survival sepsis campaign guidelines have promoted early goal-directed therapy (EGDT) as a means for reduction of mortality. On [...]

Published
2015

35. High-dose amikacin for achieving serum target levels in critically ill elderly patients

Author

Sadeghi,Kourosh, Hamishehkar,Hadi, Najmeddin,Farhad, Ahmadi,Arezoo, Hazrati,Ebrahim, Honarmand,Hooshyar, Mojtahedzadeh,Mojtaba, Sadeghi,Kourosh, Hamishehkar,Hadi, Najmeddin,Farhad, Ahmadi,Arezoo, Hazrati,Ebrahim, Honarmand,Hooshyar, and Mojtahedzadeh,Mojtaba

Abstract

Kourosh Sadeghi,1 Hadi Hamishehkar,2 Farhad Najmeddin,1 Arezoo Ahmadi,3 Ebrahim Hazrati,4 Hooshyar Honarmand,1 Mojtaba Mojtahedzadeh1,5 1Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; 2Department of Clinical Pharmacy, Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; 3Department of Anesthesia and Intensive Care, Sina Hospital, Tehran University of Medical Science, Tehran, Iran; 4Department of Anesthesia and Intensive Care, Imam Reza Hospital, Army University of Medical Sciences, Tehran, Iran; 5Pharmaceutical Sciences Research Center, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran Introduction: To achieve target concentrations, the application of higher-than-standard doses of amikacin is proposed for the treatment of sepsis due to an increase in volume of distribution and clearance, but little data are available on aminoglycoside administration in critically ill elderly patients. Patients and methods: Forty critically ill elderly patients (aged over 65 years) who required amikacin therapy due to severe documented, or suspected gram-negative infections, were randomly assigned to two treatment groups. Group A (20 patients) received 15 mg/kg amikacin and Group B (20 patients) received 25 mg/kg amikacin per day as a single daily dose. All the patients were monitored for renal damage by the daily monitoring of serum creatinine. The amikacin peak (Cmax) and trough (Cmin) serum concentrations were measured on Days 3 and 7 postadministration. Results: Data from 18 patients in Group A and 15 patients in Group B were finally analyzed. On Day 3, the amikacin mean Cmax levels in the standard and high-dose treatment groups were 30.4±11 and 52.3±16.1 µg/mL (P<0.001), and the Cmin levels were 3.2±2.1 and 5.2±2.8 µg/mL, respectively (P=0.035). On Day 7, the Cmax levels in the standard and high-dose

Published
2018

36. The role of magnesium sulfate in the intensive care unit

Author

Panahi, Yunes, Mojtahedzadeh, Mojtaba, Najafi, Atabak, Ghaini, Mohammad Reza, Abdollahi, Mohammad, Sharifzadeh, Mohammad, Ahmadi, Arezoo, Rajaee, Seyyed Mahdi, and Sahebkar, Amirhossein

Subjects
03 medical and health sciences, 0302 clinical medicine, magnesium sulfate, fungi, ICU, neuroprotection, Review Article, 030204 cardiovascular system & hematology, intensive care unit, 030217 neurology & neurosurgery
Abstract

Magnesium (Mg) has been developed as a drug with various clinical uses. Mg is a key cation in physiological processes, and the homeostasis of this cation is crucial for the normal function of body organs. Magnesium sulfate (MgSO4) is a mineral pharmaceutical preparation of magnesium that is used as a neuroprotective agent. One rationale for the frequent use of MgSO4 in critical care is the high incidence of hypomagnesaemia in intensive care unit (ICU) patients. Correction of hypomagnesaemia along with the neuroprotective properties of MgSO4 has generated a wide application for MgSO4 in ICU., EXCLI Journal; 16:Doc448; ISSN 1611-2156

Published
2017
Full Text
View/download PDF

37. Evaluation of Epithelial Lining Fluid Concentration of Amikacin in Critically Ill Patients With Ventilator-Associated Pneumonia.

Author

Najmeddin, Farhad, Shahrami, Bita, Azadbakht, Sayna, Dianatkhah, Mehrnoush, Rouini, Mohammad Reza, Najafi, Atabak, Ahmadi, Arezoo, Sharifnia, Hamidreza, and Mojtahedzadeh, Mojtaba

Subjects
BODY fluid analysis, BRONCHOALVEOLAR lavage, CRITICALLY ill, EPITHELIUM, PATIENTS, PULMONARY alveoli, TIME, PILOT projects, AMIKACIN, VENTILATOR-associated pneumonia
Abstract

Introduction: Classically, aminoglycosides are known to have low penetration into the lung tissue. So far, no study has been conducted on human adult patients to evaluate amikacin concentration in epithelial lining fluid (ELF) of the alveoli. Therefore, convincing data are not available from the perspective of pharmacokinetics to support the fact that a dosage of 20 mg/kg of amikacin is sufficient to treat patients with ventilator-associated pneumonia (VAP). Method: This was a pilot study of amikacin concentration measurement in the alveolar site of action in critically ill adult patients with VAP who required aminoglycoside therapy. A dose of 20 mg/kg of amikacin was administered over a 30-minute infusion. The serum concentrations of amikacin were evaluated in the first, second, fourth, and sixth hours. However, the ELF concentration of amikacin was evaluated in the second hour with the help of bronchoalveolar lavage sampling technique. Results: A total number of 8 patients was included in the study. The mean (SD) administered dose was 20 (0.9) mg/kg. The mean (SD) peak plasma concentration of amikacin was 59.6 (23) mg/L, with the volume of distribution of 0.36 (0.13)L/kg. The amikacin concentration in ELF was successfully measured in 7 patients (6.3) mg/L. The lung tissue penetration of the drug was described as alveolar percentage, proportional to both the first- and second-hour plasma concentrations, with a mean (SD) of 10.1% (8.4%) and 18% (16.7%), respectively. Conclusion: To our knowledge, the current study is the first that investigates whether standard doses of amikacin may lead to sufficient alveolar concentration of the drug. The results show that administration of amikacin in doses of 20 mg/kg in critically ill patients with VAP may not provide sufficient concentrations in ELF. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

47. Administration of higher doses of Amikacin in early stages of sepsis in critically ill patients

Author

Najmeddin, Farhad, Ahmadi, Arezoo, Mahmoudi, Laleh, Sadeghi, Kourosh, Khalili, Hossein, Ahmadvand, Alireza, Najafi, Atabak, Mojtahedzadeh, Mojtaba, Najmeddin, Farhad, Ahmadi, Arezoo, Mahmoudi, Laleh, Sadeghi, Kourosh, Khalili, Hossein, Ahmadvand, Alireza, Najafi, Atabak, and Mojtahedzadeh, Mojtaba

Abstract

High-dose extended-interval dosage (HDED) regimen of aminoglycosides is now considered as the standard dosage strategy in sepsis. Although safety and efficacy of this dosing regimen is well studied, but new experiments show increased the risk of resistance development associated with %T>MIC less than 60% of the dosing interval following extended interval dosing. Moreover, limited information is available about safety of more frequent administration of high dose aminoglycosides. Authors studied nephrotoxicity following seven days' exposure to more frequent administration of higher doses of amikacin comparing with HDED regimen. In addition to Serum Creatinine (SrCr) and estimated glomerular filtration rate (eGFR), nephrotoxicity was studied with Neutrophil gelatinase-associated lipocalin (NGAL), a direct marker of tubular injury. A total of 40 patients with sepsis were quasi-randomized in two groups. Seven days' course of treatment with a moderate dose of amikacin (12.5 mg/Kg) was administered every 12 hours, known as the moderate-dose non-liberal-interval dosage (MDNLD) regimen compared with the high-dose extended-interval dosage (HDED) regimen (25 mg/Kg every 24 hours). The pharmacokinetic/pharmacodynamic (PK/PD) goal of the MDNLD regimen was the Cmax>40 and the %T>MIC more than 60% during the PK/PD goal for the HDED regimen was the Cmax>60. The eGFR change from the baseline was the primary outcome of the study with a minimum clinical significance of 20 ml/min (estimated SD of 20, Power>90%, P<0.05). No difference was observed between groups for the values of eGFR change and the SrCr percent change from the baseline (P=0.359 and P=0.114, respectively). Frequency of acute kidney injury also did not differ between groups (P=0.342). Serum NGAL level values' change from the baseline was more in the HDED regimen in comparison with the MDNLD regimen at third day and fifth day of the treatment (P=0.001 and P =0.002, respectively). This in

Published
2014

48. An Iranian Consensus Document for Nutrition in Critically Ill Patients, Recommendations and Initial Steps toward Regional Guidelines.

Author

Hashemian, Seyed Mohammadreza, Martindale, Robert G., Jamaati, Hamidreza, Amirsavadkouhi, Ali, Azer, Salahaddin Mahmudi, Shadnoush, Mahdi, Ardehali, Seyed Hossein, Najafi, Atabak, Ahmadi, Arezoo, Seyyedi, Seyyed Reza, Mahmoodpoor, Ata, Moradi, Omid, Abbasi, Saeed, Hosseini, Saeed, Shahrami, Reza, Abdi, Saeed, Sepehri, Zahra, Omranirad, Babak, Mohajerani, Seyed Amir, and Rohani, Pejman

Subjects
CRITICALLY ill, NUTRITION
Published
2017

50. Invasive candidiasis in intensive care unit; consensus statement from an Iranian panel of experts, July 2013

Author

Ahmadi, Arezoo, primary, Ardehali, Seyed Hossein, additional, Beigmohammadi, Mohammad Taghi, additional, Hajiabdolbaghi, Mahboubeh, additional, Hashemian, Seyed Mohammad Reza, additional, Kouchek, Mehran, additional, Majidpour, Ali, additional, Mokhtari, Majid, additional, Moghaddam, Omid Moradi, additional, Najafi, Atabak, additional, Nejat, Reza, additional, Niakan, Mohammad, additional, Lotfi, Amir Hossein, additional, Amirsavadkouhi, Ali, additional, Shirazian, Farzad, additional, Tabarsi, Payam, additional, Taher, Mahshid Talebi, additional, and Torabi-Nami, Mohammad, additional

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results